Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Hudson

Showing results (361-370 of 400) with videos related to

Pageof 40
Sort By:
Cancer|January 12, 2019
The effects of a randomized trial of brief forms of stress management on RAGE-associated S100A8/A9 in patients with breast cancer undergoing primary treatmentChloe J Taub, Marc E Lippman, Barry I Hudson, et al.
Diabetes & Vascular Disease Research|April 7, 2010
Inflammatory stress in primary venous and aortic endothelial cells of type 1 diabetic miceLoredana G Bucciarelli, Andreas Pollreisz, Moritz Kebschull, et al.
Diabetes & Vascular Disease Research|November 25, 2005
RAGE and its ligands: a lasting memory in diabetic complications?Shi-Fang Yan, Ravichandran Ramasamy, Loredana G Bucciarelli, et al.
Arthritis and Rheumatism|March 30, 2007
Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trialLesley M Arnold, Don L Goldenberg, Sharon B Stanford, et al.
Atherosclerosis|September 21, 2014
High-density lipoprotein subfractions and carotid plaque: the Northern Manhattan StudyEduard Tiozzo, Hannah Gardener, Barry I Hudson, et al.
The American Journal of Psychiatry|December 8, 1998
Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trialJ I Hudson, S L McElroy, N C Raymond, et al.
Journal of Psychiatric Research|June 10, 2014
Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of responseBrian P Brennan, Catherine Lee, Jason A Elias, et al.
Atherosclerosis|February 15, 2011
Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS)Barry I Hudson, Yeseon Park Moon, Anastasia Z Kalea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II studyG J Creemers, G Bolis, M Gore, et al.
The American Journal of Clinical Nutrition|April 30, 2010
Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorderJames I Hudson, Justine K Lalonde, Caitlin E Coit, et al.
Pageof 40

Showing results (361-370 of 400) with videos related to

Sort By:
Pageof 40
Cancer|January 12, 2019
The effects of a randomized trial of brief forms of stress management on RAGE-associated S100A8/A9 in patients with breast cancer undergoing primary treatmentChloe J Taub, Marc E Lippman, Barry I Hudson, et al.
Diabetes & Vascular Disease Research|April 7, 2010
Inflammatory stress in primary venous and aortic endothelial cells of type 1 diabetic miceLoredana G Bucciarelli, Andreas Pollreisz, Moritz Kebschull, et al.
Diabetes & Vascular Disease Research|November 25, 2005
RAGE and its ligands: a lasting memory in diabetic complications?Shi-Fang Yan, Ravichandran Ramasamy, Loredana G Bucciarelli, et al.
Arthritis and Rheumatism|March 30, 2007
Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trialLesley M Arnold, Don L Goldenberg, Sharon B Stanford, et al.
Atherosclerosis|September 21, 2014
High-density lipoprotein subfractions and carotid plaque: the Northern Manhattan StudyEduard Tiozzo, Hannah Gardener, Barry I Hudson, et al.
The American Journal of Psychiatry|December 8, 1998
Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trialJ I Hudson, S L McElroy, N C Raymond, et al.
Journal of Psychiatric Research|June 10, 2014
Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of responseBrian P Brennan, Catherine Lee, Jason A Elias, et al.
Atherosclerosis|February 15, 2011
Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS)Barry I Hudson, Yeseon Park Moon, Anastasia Z Kalea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II studyG J Creemers, G Bolis, M Gore, et al.
The American Journal of Clinical Nutrition|April 30, 2010
Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorderJames I Hudson, Justine K Lalonde, Caitlin E Coit, et al.
Pageof 40